130 related articles for article (PubMed ID: 27724895)
1. Hepatitis B virus inhibits apolipoprotein A5 expression through its core gene.
Zhu C; Gao G; Song H; Xu F; Wu K; Liu X
Lipids Health Dis; 2016 Oct; 15(1):178. PubMed ID: 27724895
[TBL] [Abstract][Full Text] [Related]
2. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3.
Zhu C; Zhu H; Song H; Xu L; Li L; Liu F; Liu X
Lipids Health Dis; 2017 Nov; 16(1):213. PubMed ID: 29132372
[TBL] [Abstract][Full Text] [Related]
4. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.
Wang Y; Hao J; Liu X; Wang H; Zeng X; Yang J; Li L; Kuang X; Zhang T
Lipids Health Dis; 2016 Mar; 15():64. PubMed ID: 27015844
[TBL] [Abstract][Full Text] [Related]
5. Serum apolipoprotein C3 levels are negatively associated with hepatitis B virus DNA in HBeAg-negative chronic hepatitis B patients.
Cui Y; Cui XD; Xu M; Fang M; Cai MJ
Lipids Health Dis; 2019 Jun; 18(1):138. PubMed ID: 31186008
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases.
Zhu C; Han H; Li J; Xu L; Liu F; Wu K; Liu X
Biomed Res Int; 2019; 2019():9321494. PubMed ID: 31240230
[TBL] [Abstract][Full Text] [Related]
7. Investigation into the effect of hepatitis B virus on apoliprotein A1 expression and its mechanism.
Jiang W; Zheng L; Yang Q; Huang Z; Wang X
Lipids Health Dis; 2014 Aug; 13():130. PubMed ID: 25115832
[TBL] [Abstract][Full Text] [Related]
8. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
9. [Study of the effect and mechanism of spastic paraplegia 21 protein on the replication of hepatitis B virus].
Gao GS; Weng PJ; Li RY; Ding SX
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):747-50. PubMed ID: 22409846
[TBL] [Abstract][Full Text] [Related]
10. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
[TBL] [Abstract][Full Text] [Related]
11. HBV inhibits apoB production via the suppression of MTP expression.
Wang FB; Zhu CL; Liu X; Gao GS
Lipids Health Dis; 2011 Nov; 10():207. PubMed ID: 22074108
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
Li R; Zhu W; Huang P; Ding C; Tang Y; Lian P; Huang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):730-738. PubMed ID: 35837772
[TBL] [Abstract][Full Text] [Related]
13. [Effect of hepatitis B virus X gene on the expression of spastic paraplegia 21].
Gao GS; Weng PJ; Ji RB; Li DZ; Li YY; Li HS; Ding SX; Hu J
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):920-3. PubMed ID: 21205478
[TBL] [Abstract][Full Text] [Related]
14. [Effects of partial deletion in the core promoter of hepatitis B virus genome on viral antigen expressions].
Peng J; Luo KX; Hou JL; Guo YB; Wang ZH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):306-8. PubMed ID: 12390729
[TBL] [Abstract][Full Text] [Related]
15. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
16. [Regulation of the hepatitis B virus X promoter activity by a novel negative regulatory element].
Yang Y; Wu Y; Zhang WL; Yu B; Huang AL
Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):893-6. PubMed ID: 18171521
[TBL] [Abstract][Full Text] [Related]
17. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
18. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine leads to nonalcoholic fatty liver disease through the apolipoprotein A5 pathway.
Li R; Zhu W; Huang P; Yang Y; Luo F; Dai W; Shen L; Pei W; Huang X
Biomed Pharmacother; 2021 Sep; 141():111803. PubMed ID: 34146854
[TBL] [Abstract][Full Text] [Related]
20. HBV Upregulates CtBP2 Expression via the X Gene.
Liu X; Zhu C; Li J; Xu F; Huang G; Xu L; Zhang B
Biomed Res Int; 2018; 2018():6960573. PubMed ID: 30151388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
